Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Evaluation of the INTERGROWTH-21st project newborn standard for use in Canada.

Liu S, Metcalfe A, León JA, Sauve R, Kramer MS, Joseph KS; Canadian Perinatal Surveillance System (Public Health Agency of Canada).

PLoS One. 2017 Mar 3;12(3):e0172910. doi: 10.1371/journal.pone.0172910. eCollection 2017.

2.

External validation of the Revised Cardiac Risk Index and update of its renal variable to predict 30-day risk of major cardiac complications after non-cardiac surgery: rationale and plan for analyses of the VISION study.

Roshanov PS, Walsh M, Devereaux PJ, MacNeil SD, Lam NN, Hildebrand AM, Acedillo RR, Mrkobrada M, Chow CK, Lee VW, Thabane L, Garg AX.

BMJ Open. 2017 Jan 9;7(1):e013510. doi: 10.1136/bmjopen-2016-013510.

3.

Endometrial Cancer Risk Factors, Hormone Receptors, and Mortality Prediction.

Busch EL, Crous-Bou M, Prescott J, Chen MM, Downing MJ, Rosner BA, Mutter GL, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):727-735. doi: 10.1158/1055-9965.EPI-16-0821. Epub 2017 Jan 4.

PMID:
28052940
4.

Development and Internal Validation of a Predictive Model Including Pulse Oximetry for Hospitalization of Under-Five Children in Bangladesh.

Raihana S, Dunsmuir D, Huda T, Zhou G, Rahman QS, Garde A, Moinuddin M, Karlen W, Dumont GA, Kissoon N, El Arifeen S, Larson C, Ansermino JM.

PLoS One. 2015 Nov 18;10(11):e0143213. doi: 10.1371/journal.pone.0143213. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0147560.

5.

Prediction of coronary artery disease risk based on multiple longitudinal biomarkers.

Yang L, Yu M, Gao S.

Stat Med. 2016 Apr 15;35(8):1299-314. doi: 10.1002/sim.6754. Epub 2015 Oct 5.

6.

A Risk Assessment Tool to Predict Sustained PTSD Symptoms Among Women Reporting Abuse.

Symes L, Maddoux J, McFarlane J, Pennings J.

J Womens Health (Larchmt). 2016 Apr;25(4):340-7. doi: 10.1089/jwh.2015.5287. Epub 2015 Aug 12.

7.

Five-minute Apgar score as a marker for developmental vulnerability at 5 years of age.

Razaz N, Boyce WT, Brownell M, Jutte D, Tremlett H, Marrie RA, Joseph KS.

Arch Dis Child Fetal Neonatal Ed. 2016 Mar;101(2):F114-20. doi: 10.1136/archdischild-2015-308458. Epub 2015 Jul 17.

8.

Recalibration and validation of the Charlson comorbidity index in Korean incident hemodialysis patients.

Park JY, Kim MH, Han SS, Cho H, Kim H, Ryu DR, Kim H, Lee H, Lee JP, Lim CS, Kim KH, Joo KW, Kim YS, Kim DK; Clinical Research Center for End Stage Renal Disease (CRC for ESRD) Investigators.

PLoS One. 2015 May 18;10(5):e0127240. doi: 10.1371/journal.pone.0127240. eCollection 2015.

9.

Risk reclassification analysis investigating the added value of fatigue to sickness absence predictions.

Roelen CA, Bültmann U, Groothoff JW, Twisk JW, Heymans MW.

Int Arch Occup Environ Health. 2015 Nov;88(8):1069-75. doi: 10.1007/s00420-015-1032-3. Epub 2015 Feb 22.

10.

Measurement of ECG abnormalities and cardiovascular risk classification: a cohort study of primary care patients in the Netherlands.

Groot A, Bots ML, Rutten FH, den Ruijter HM, Numans ME, Vaartjes I.

Br J Gen Pract. 2015 Jan;65(630):e1-8. doi: 10.3399/bjgp15X683089.

11.

Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes.

Baker SG, Kramer BS.

Clin Trials. 2015 Aug;12(4):299-308. doi: 10.1177/1740774514557725. Epub 2014 Nov 10.

12.

Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.

Lee CP, Irwanto A, Salim A, Yuan JM, Liu J, Koh WP, Hartman M.

Breast Cancer Res. 2014 Jun 18;16(3):R64. doi: 10.1186/bcr3678.

13.

Risk prediction score for death of traumatised and injured children.

Vallipakorn SA, Plitapolkarnpim A, Suriyawongpaisal P, Techakamolsuk P, Smith GA, Thakkinstian A.

BMC Pediatr. 2014 Feb 28;14:60. doi: 10.1186/1471-2431-14-60.

14.

A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.

Payne BA, Hutcheon JA, Ansermino JM, Hall DR, Bhutta ZA, Bhutta SZ, Biryabarema C, Grobman WA, Groen H, Haniff F, Li J, Magee LA, Merialdi M, Nakimuli A, Qu Z, Sikandar R, Sass N, Sawchuck D, Steyn DW, Widmer M, Zhou J, von Dadelszen P; miniPIERS Study Working Group.

PLoS Med. 2014 Jan;11(1):e1001589. doi: 10.1371/journal.pmed.1001589. Epub 2014 Jan 21.

15.

Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals.

Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS.

Clin J Am Soc Nephrol. 2014 Jan;9(1):12-20. doi: 10.2215/CJN.02730313. Epub 2013 Oct 31.

16.

Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts.

Yende S, Alvarez K, Loehr L, Folsom AR, Newman AB, Weissfeld LA, Wunderink RG, Kritchevsky SB, Mukamal KJ, London SJ, Harris TB, Bauer DC, Angus DC; Atherosclerosis Risk in Communities Study, the Cardiovascular Health Study, and the Health, Aging, and Body Composition Study.

Chest. 2013 Sep;144(3):1008-1017. doi: 10.1378/chest.12-2818.

17.

Two-stage sampling designs for external validation of personal risk models.

Whittemore AS, Halpern J.

Stat Methods Med Res. 2016 Aug;25(4):1313-29. doi: 10.1177/0962280213480420. Epub 2013 Apr 16.

18.

Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.

Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW.

PLoS One. 2013;8(1):e51926. doi: 10.1371/journal.pone.0051926. Epub 2013 Jan 18.

19.

Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts.

Cross DS, McCarty CA, Hytopoulos E, Beggs M, Nolan N, Harrington DS, Hastie T, Tibshirani R, Tracy RP, Psaty BM, McClelland R, Tsao PS, Quertermous T.

Curr Med Res Opin. 2012 Nov;28(11):1819-30. doi: 10.1185/03007995.2012.742878.

20.

Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.

Olmos D, Brewer D, Clark J, Danila DC, Parker C, Attard G, Fleisher M, Reid AH, Castro E, Sandhu SK, Barwell L, Oommen NB, Carreira S, Drake CG, Jones R, Cooper CS, Scher HI, de Bono JS.

Lancet Oncol. 2012 Nov;13(11):1114-24. doi: 10.1016/S1470-2045(12)70372-8. Epub 2012 Oct 9.

Supplemental Content

Support Center